Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12040)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 21, 2015 (publication date) through Dec 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kubo S, Takemura S, Tanaka S, Shinkawa H, Nishioka T, Nozawa A, Kinoshita M, Hamano G, Ito T, Urata Y. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2015; 21(27): 8249-8255 [PMID: 26217076 DOI: 10.3748/wjg.v21.i27.8249] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i27/8249.htm |
| Number | Citing Articles |
| 1 |
Chiao-Fang Teng, Tsai-Chung Li, Hsi-Yuan Huang, Wen-Ling Chan, Han-Chieh Wu, Woei-Cherng Shyu, Ih-Jen Su, Long-Bin Jeng, Jason Blackard. Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection. PLOS ONE 2020; 15(11): e0242748 doi: 10.1371/journal.pone.0242748
|
| 2 |
Si-si Zhang, Jin-feng Zhang, Jing-qiong Wang, Jing Tang, Zi-long Wu, Jing Huang, Jun Xue. Liver Transplantation Outcomes of HBV-, HCV-, and Alcohol-induced Hepatocellular Carcinoma in the United States: Analysis of National Inpatient Samples. Current Medical Science 2023; 43(3): 520 doi: 10.1007/s11596-023-2718-5
|
| 3 |
Guangcong Zhang, Xiangnan Yu, Peng Liu, Xiaoxi Huang, Xuemei Jiang. Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis. Digestive Diseases and Sciences 2018; 63(12): 3207 doi: 10.1007/s10620-018-5252-8
|
| 4 |
Musomba Rachel, Castelnuovo Barbara, Claire Murphy, Charlene Komujuni, Patience Nyakato, Ponsiano Ocama, Mohammed Lamorde, Philippa Easterbrook, Rosalind Parkes Ratanshi. Uptake of hepatitis B-HIV co-infection screening and management in a resource limited setting. Hepatology, Medicine and Policy 2018; 3(1) doi: 10.1186/s41124-017-0030-3
|
| 5 |
Chiao-Fang Teng, Chun-Hui Yu, Hong-Yi Chang, Wen-Chuan Hsieh, Tzu-Hua Wu, Jia-Hui Lin, Han-Chieh Wu, Long-Bin Jeng, Ih-Jen Su. Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46891-5
|
| 6 |
Chiao-Fang Teng, Hung-Wen Tsai, Tsai-Chung Li, Ting Wang, John Wang, Woei-Cherng Shyu, Han-Chieh Wu, Ih-Jen Su, Long-Bin Jeng, Pierre Roques. Detection of hepatitis B virus pre-S mutants in plasma by a next-generation sequencing-based platform determines their patterns in liver tissues. PLOS ONE 2020; 15(6): e0234773 doi: 10.1371/journal.pone.0234773
|
| 7 |
Kazuhiro Takahashi, Krishna G Putchakayala, Mohamed Safwan, Dean Y Kim. Extrahepatic metastasis of hepatocellular carcinoma to the paravertebral muscle: A case report. World Journal of Hepatology 2017; 9(22): 973-978 doi: 10.4254/wjh.v9.i22.973
|
| 8 |
Long‐Bin Jeng, Tsai‐Chung Li, John Wang, Chiao‐Fang Teng. Increased plasma levels of monocyte chemoattractant protein‐1 in patients with hepatitis B virus pre‐S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection. Cancer 2023; 129(17): 2621 doi: 10.1002/cncr.34815
|
| 9 |
Pengfei Zhang, Yu Yang, Feng Wen, John Wheeler, Ping Fu, Qiu Li. Cost‐effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus‐related hepatocellular carcinoma treated with sorafenib. Journal of Gastroenterology and Hepatology 2016; 31(12): 1978 doi: 10.1111/jgh.13425
|
| 10 |
Jiansong Wu, Zhiwei Yin, Liuxia Cao, Xiaodan Xu, Tao Yan, Changting Liu, Diangeng Li. Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment. Medicine 2018; 97(28): e11295 doi: 10.1097/MD.0000000000011295
|
| 11 |
Kerstin Schütte, Fathi Balbisi, Peter Malfertheiner. Prevention of Hepatocellular Carcinoma. Gastrointestinal Tumors 2016; 3(1): 37 doi: 10.1159/000446680
|
| 12 |
Long-Bin Jeng, Tsai-Chung Li, Wen-Ling Chan, Chiao-Fang Teng. Combination of Hepatitis B Virus Pre-S2 Gene Deletion Mutation and Tumor-Node-Metastasis Stage Predicts Higher Hepatocellular Carcinoma Recurrence after Curative Surgical Resection. Biomedicines 2023; 11(3): 923 doi: 10.3390/biomedicines11030923
|
| 13 |
Masaki Koda, Shogo Tanaka, Shigekazu Takemura, Hiroji Shinkawa, Masahiko Kinoshita, Genya Hamano, Tokuji Ito, Norifumi Kawada, Toshihiko Shibata, Shoji Kubo. Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status. Liver Cancer 2018; 7(3): 261 doi: 10.1159/000486902
|
| 14 |
Chiao-Fang Teng, Hsi-Yuan Huang, Tsai-Chung Li, Woei-Cherng Shyu, Han-Chieh Wu, Chien-Yu Lin, Ih-Jen Su, Long-Bin Jeng. A Next-Generation Sequencing-Based Platform for Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma of Hepatocellular Carcinoma Patients. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33051-4
|
| 15 |
Wu Shanshan, Du Xinfang, Yu Shuihong, Lai Kecong, Qi Jinjin, Chen Zhi, Chen Feng. Pathological changes of liver one year later in CHB patients with negative HBV DNA. Infectious Agents and Cancer 2019; 14(1) doi: 10.1186/s13027-019-0265-2
|
| 16 |
Chiao-Fang Teng, Tsai-Chung Li, Ting Wang, Da-Ching Liao, Yi-Hsuan Wen, Tzu-Hua Wu, John Wang, Han-Chieh Wu, Woei-Cherng Shyu, Ih-Jen Su, Long-Bin Jeng. Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80935-5
|
| 17 |
Yanhua Ding, Jinfeng Lou, Hong Chen, Xiaojiao Li, Min Wu, Cuiyun Li, Jingrui Liu, Chengjiao Liu, Qingmei Li, Hong Zhang, Junqi Niu. Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection. British Journal of Clinical Pharmacology 2017; 83(5): 1056 doi: 10.1111/bcp.13184
|
| 18 |
Peng Yuan, Yeben Qian, Peng Chen. Response to: Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”. Canadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/5210902
|
| 19 |
Yusha Xiao, Baiyang Chen, Kang Yang, Quanxiong Wang, Pengpeng Liu, Yang Gu, Qiu Zhong, Zhisu Liu, Yueming He, Quanyan Liu. Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma. Experimental Cell Research 2019; 383(2): 111542 doi: 10.1016/j.yexcr.2019.111542
|
| 20 |
Yen-Hao Chen, Chih-Chi Wang, Yen-Yang Chen, Jing-Houng Wang, Chao-Hung Hung, Yuan-Hung Kuo. Low-dose nivolumab in advanced hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10271-6
|
| 21 |
Baoxin Zhao, Hongxiu Qiao, Yan Zhao, Zhiyun Gao, Weijie Wang, Yan Cui, Jian Li, Zhanjun Guo, Xia Chuai, Sandra Chiu. HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK/MAPK pathway. Virologica Sinica 2023; 38(5): 680 doi: 10.1016/j.virs.2023.06.004
|
| 22 |
Long-Bin Jeng, Tsai-Chung Li, Shih-Chao Hsu, Wen-Ling Chan, Chiao-Fang Teng. Association of Low Serum Albumin Level with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection. Journal of Clinical Medicine 2021; 10(18): 4187 doi: 10.3390/jcm10184187
|